United States

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

20 Jan 2017
Change (% chg)

¥-3 (-0.34%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4571.T


NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The... (more)


Beta: 2.12
Market Cap(Mil.): ¥38,166.16
Shares Outstanding(Mil.): 43.17
Dividend: --
Yield (%): --


  4571.T Industry Sector
P/E (TTM): -- 44.51 30.50
EPS (TTM): -79.44 -- --
ROI: -25.10 -1.38 14.85
ROE: -27.68 -1.00 16.27

BRIEF-NanoCarrier gets substance patent grant in EU

* Says it received substance patent grant from European Patent Office

Jan 11 2017

BRIEF-NanoCarrier cancels cancer medicine licensing and joint development contract with Kowa Company Ltd

* Says the co canceled the licensing for a cancer medicine NC-6300(K-912) and joint development cooperation contract with Kowa Company Ltd, which was signed on Sep. 26. 2011

Oct 21 2016

BRIEF-NanoCarrier affirms safety profile and efficacy of NC-6004 in Phase Ib clinical study in US

* Says it confirmed safety profile and efficacy of NC-6004 in the Phase Ib clinical study conducted in the U.S.

Oct 11 2016

BRIEF-Bind Therapeutics determines Pfizer's $40 mln bid highest

* Plans to disclose additional terms of its agreement with Pfizer upon court approval.

Jul 26 2016

Earnings vs. Estimates